F10 |
F10: Coagulation factor X precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
0.255 |
Evidence |
|
FCGR1A |
FCGR1A, FCG1, FCGR1, IGFR1: High affinity immunoglobulin gamma Fc receptor I pre |
LILRB2 |
IPI00303952 |
0.255 |
Evidence |
|
OSTF1 |
IPI00333434 |
JAK1 |
|
0.255 |
Evidence |
|
NCR3 |
NCR3, 1C7, LY117: Natural cytotoxicity triggering receptor 3 precursor |
MYOM2 |
MYOM2: Myomesin-2 |
0.255 |
Evidence |
|
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
0.255 |
Evidence |
|
RBP4 |
RBP4, PRO2222: Plasma retinol-binding protein precursor |
C6 |
C6: Complement component C6 precursor |
0.255 |
Evidence |
|
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
CPSF6 |
CPSF6, CFIM68: Cleavage and polyadenylation specificity factor subunit 6 |
0.255 |
Evidence |
|
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGAP4 |
ARHGAP4, KIAA0131, RGC1, RHOGAP4: Rho GTPase-activating protein 4 |
0.255 |
Evidence |
|
TLR7 |
TLR7, UNQ248/PRO285: Toll-like receptor 7 precursor |
FCER1A |
FCER1A, FCE1A: High affinity immunoglobulin epsilon receptor subunit alpha precu |
0.255 |
Evidence |
|
HNRPR |
HNRPR: Heterogeneous nuclear ribonucleoprotein R |
RBMX |
RBMX, HNRPG, RBMXP1: Heterogeneous nuclear ribonucleoprotein G |
0.255 |
Evidence |
|
CD86 |
CD86, CD28LG2: T-lymphocyte activation antigen CD86 precursor |
IGSF6 |
IGSF6, DORA: Immunoglobulin superfamily member 6 precursor. |
0.255 |
Evidence |
|
C2 |
C2: Complement C2 precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
SFRS5 |
SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 |
PARP12 |
PARP12, ZC3HDC1: Poly [ADP-ribose] polymerase 12 |
0.255 |
Evidence |
|
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
CD93 |
CD93, C1QR1, MXRA4: Complement component C1q receptor precursor |
0.255 |
Evidence |
|
WISP2 |
WISP2, CCN5, UNQ228/PRO261, CT58, CTGFL: WNT1-inducible-signaling pathway protei |
ADIPOQ |
ADIPOQ, ACDC, ACRP30, APM1, GBP28: Adiponectin precursor |
0.255 |
Evidence |
|
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
CPSF6 |
CPSF6, CFIM68: Cleavage and polyadenylation specificity factor subunit 6 |
0.255 |
Evidence |
|
CD7 |
CD7: T-cell antigen CD7 precursor |
MYOM2 |
MYOM2: Myomesin-2 |
0.255 |
Evidence |
|
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
SCAP2 |
SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R: Src kinase-associated phosphoprotein 2 |
0.255 |
Evidence |
|
HMGN4 |
HMGN4, HMG17L3, NHC: High mobility group nucleosome-binding domain-containing pr |
RP6-213H19.1 |
MST4, MASK: Serine/threonine-protein kinase MST4 |
0.255 |
Evidence |
|
ITGB7 |
ITGB7: Integrin beta-7 precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.255 |
Evidence |
|
PSG2 |
PSG2, PSBG2: Pregnancy-specific beta-1-glycoprotein 2 precursor |
TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
0.255 |
Evidence |
|
LILRA3 |
LILRA3, ILT6, LIR4: Leukocyte immunoglobulin-like receptor subfamily A member 3 |
LILRB1 |
IPI00385703 |
0.255 |
Evidence |
|
NCR3 |
NCR3, 1C7, LY117: Natural cytotoxicity triggering receptor 3 precursor |
CD160 |
CD160, BY55: CD160 antigen precursor |
0.255 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
CLEC2B |
CLEC2B, AICL, CLECSF2, IFNRG1: C-type lectin domain family 2 member B |
0.255 |
Evidence |
|